Leukocyte Trafficking via Lymphatic Vessels in Atherosclerosis
- PMID: 34072313
- PMCID: PMC8229118
- DOI: 10.3390/cells10061344
Leukocyte Trafficking via Lymphatic Vessels in Atherosclerosis
Abstract
In recent years, lymphatic vessels have received increasing attention and our understanding of their development and functional roles in health and diseases has greatly improved. It has become clear that lymphatic vessels are critically involved in acute and chronic inflammation and its resolution by supporting the transport of immune cells, fluid, and macromolecules. As we will discuss in this review, the involvement of lymphatic vessels has been uncovered in atherosclerosis, a chronic inflammatory disease of medium- and large-sized arteries causing deadly cardiovascular complications worldwide. The progression of atherosclerosis is associated with morphological and functional alterations in lymphatic vessels draining the diseased artery. These defects in the lymphatic vasculature impact the inflammatory response in atherosclerosis by affecting immune cell trafficking, lymphoid neogenesis, and clearance of macromolecules in the arterial wall. Based on these new findings, we propose that targeting lymphatic function could be considered in conjunction with existing drugs as a treatment option for atherosclerosis.
Keywords: adventitia; atherosclerosis; cholesterol; immune cells; inflammation; lymphangiogenesis; lymphatic vessel.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures


Similar articles
-
Lymphatic vessels: an emerging actor in atherosclerotic plaque development.Eur J Clin Invest. 2015 Jan;45(1):100-8. doi: 10.1111/eci.12372. Eur J Clin Invest. 2015. PMID: 25388153 Review.
-
Cardiac lymphatics in health and disease.Nat Rev Cardiol. 2019 Jan;16(1):56-68. doi: 10.1038/s41569-018-0087-8. Nat Rev Cardiol. 2019. PMID: 30333526 Review.
-
Cardiac Lymphatics - A New Avenue for Therapeutics?Trends Endocrinol Metab. 2017 Apr;28(4):285-296. doi: 10.1016/j.tem.2016.12.002. Epub 2017 Jan 10. Trends Endocrinol Metab. 2017. PMID: 28087126 Review.
-
Adventitial lymphatic vessels -- an important role in atherosclerosis.Med Hypotheses. 2007;69(6):1238-41. doi: 10.1016/j.mehy.2007.04.007. Epub 2007 Sep 6. Med Hypotheses. 2007. PMID: 17825501
-
The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.Cell. 2020 Jul 23;182(2):270-296. doi: 10.1016/j.cell.2020.06.039. Cell. 2020. PMID: 32707093 Free PMC article. Review.
Cited by
-
Abnormal Lymphatic Sphingosine-1-Phosphate Signaling Aggravates Lymphatic Dysfunction and Tissue Inflammation.Circulation. 2023 Oct 17;148(16):1231-1249. doi: 10.1161/CIRCULATIONAHA.123.064181. Epub 2023 Aug 23. Circulation. 2023. PMID: 37609838 Free PMC article.
-
Zebrafish Models of Induced Lymphangiogenesis: Current Advancements and Therapeutic Discovery.Pharmaceuticals (Basel). 2025 Jul 21;18(7):1076. doi: 10.3390/ph18071076. Pharmaceuticals (Basel). 2025. PMID: 40732363 Free PMC article. Review.
-
Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation.medRxiv [Preprint]. 2023 Jun 12:2023.06.08.23291175. doi: 10.1101/2023.06.08.23291175. medRxiv. 2023. Update in: Circulation. 2023 Oct 17;148(16):1231-1249. doi: 10.1161/CIRCULATIONAHA.123.064181. PMID: 37398237 Free PMC article. Updated. Preprint.
-
Limited Proteolysis as a Regulator of Lymphatic Vessel Function and Architecture.Int J Mol Sci. 2025 Jul 24;26(15):7144. doi: 10.3390/ijms26157144. Int J Mol Sci. 2025. PMID: 40806273 Free PMC article. Review.
-
Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis.FASEB J. 2022 Mar;36(3):e22173. doi: 10.1096/fj.202101219RR. FASEB J. 2022. PMID: 35104001 Free PMC article. Clinical Trial.
References
-
- Srinivasan R.S., Escobedo N., Yang Y., Interiano A., Dillard M.E., Finkelstein D., Mukatira S., Gil H.J., Nurmi H., Alitalo K., et al. The Prox1–Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev. 2014;28:2175–2187. doi: 10.1101/gad.216226.113. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials